In vitro Dissolution and Pharmacokinetics in Beagle Dogs of a Self-Emulsifying Formulation of Tretinoin

Abstract

Abstract: Aim In vitro dissolution test and pharmacokinetics in beagle dogs were conducted to assess the formulation of tretinoin in self-emulsifying systems. Methods The concentrations of tretinoin were determined by HPLC. A crossover study was performed in four fasting beagle dogs with the formulation of self-emulsifying systems and commercial capsules. Results The results showed that the dissolution rate in 15 min of tretinoin in self-emulsifying systems was higher than 80% while that of the commercial capsules was lower than 5%. The area under the plasma concentration-time curve (AUC) of the self-emulsifying formulation was significantly higher and Cmax was approximately two times greater than those of commercial capsule, respectively. In addition, the time taken to reach peak was shorter (2 h to 1.25 h) for self-emulsifying formulation of tretinoin. Conclusion The self-emulsifying drug delivery systems can significantly increase tretinoin in vitro dissolution and in vivo absorption.

Key words: self-emulsifying systems, self-emulsifying systems, tretinoin, tretinoin, bioavailability, bioavailability, dissolution, dissolution

CLC Number:

R969.1

Supporting:

QUAN Dong-qin^*, XU Gui-xia. In vitro Dissolution and Pharmacokinetics in Beagle Dogs of a Self-Emulsifying Formulation of Tretinoin[J]. .

References

[1] Chivot M. Retinoid therapy for acne : a comparative review [J]. Am Clin Dermatol, 2005, 6 (1) : 13-19.
[2] Dai X, Yamasaki K, Shirakata Y, et al. All-trans-retinoic acid induces interleukin-8 via the nuclear factor-kappa B and p38 mitogen-activated protein kinase pathways in normal human keratinocytes [J]. J Invest Dermatol, 2004, 123 (6) : 1078-1085.
[3] Parthasarathy R, Gilbert B, Mehta K. Aerosol delivery of liposomal all-trans-retinoic acid to the lungs [J]. Cancer Chemother Pharmacol, 1994, 43 : 277-283.
[4] Jenning V, Gohla SH. Encapsulation of retinoids in solid lipid nanoparticles (SLN). J Microencapsulation [J]. 2001, 18 : 149-158.
[5] Lin HS, Chean CS, Ng YY, et al. 2-Hydroxypropyl-beta-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid [J]. J Clin Pharm Ther, 2000, 25 : 265-269.
[6] Porter CJH, Charman WN. In vitro assessment of oral lipid based formulation [J]. Adv Drug Del, 2001, 50 (suppl 1) : S127-147.
[7] Charman SA, Charman WN, Rogge MC, et al. Self-emulsifying drug delivery systems : formulation and biopharmaceutic evaluation of an investigational lipophilic compound [J]. Pharm Res, 1992, 9 : 87-93.
[8] Pouton CW. Lipid formulation for oral administration of drugs : Non-emulsifying, self-emulsifying and self-microemulsifying drug delivery systems [J]. Eur J Pharm Sci, 11 : S93-98.
[9] Gao P, Witt MJ, Haskell RJ, et al. Application of a mixture experimental design in the optimization of a self-emulsifying formulation with a high drug load [J]. Pharm Dev Technol, 2004, 9 (3) : 301-309.
[10] Palamakula A, Khan MA. Evaluation of cytotoxicity of oils used in coenzyme Q10 self-emulsifying drug delivery systems (SEDDS) [J]. Int J Pharm, 2004, 273 (1-2) : 63-73.
[11] Pouton CW, Self-emulsifying drug delivery systems : assessment of the efficiency of emulsification [J]. Int J Pharm, 1985, 27 (2) : 335-348.
[12] Tarr BD, Yalkowsky SH. Enhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet size [J]. Pharm Res, 1989, 6 : 40-43.
[13] Shah NH, Carvajal MT, Patel CI, et al. Self-emulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs [J]. Int J Pharm, 1994, 106 :15-23.
[14] Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs [J]. Biomed Pharmacother, 2004, 58 (3) : 173-182.
[15] Craig DQM. The use of self-emulsifying systems as a means of improving drug delivery [J]. B T Gattefosse, 1993, 86 : 21-31.
[16] Catherine T, Michael N, Steven B, et al. Comparative bioavailability study in dogs of a self-emulsifying formulation of progesterone presented in a pellet and liquid form compared with an aqueous suspension of progesterone [J]. J Pharm Sci, 2004, 93 (6) : 1495-1502.
[17] Julianto T, Yuen KH, Noor AM. Improved bioavailability of vitamin E with a self emulsifying formulation [J]. Int J Pharm, 2000, 200 (1) : 53-57.
[18] Barkera SA, Yapb SP, Yuenb KH, et al. An investigation into the structure and bioavailability of tocopherol dispersions in Gelucire 44/14 [J]. J Controlled Release, 2003, 91 : 477-488.
[19] Nilüfer Yüksel, Aysegül Karataa, Yalçln ; Özkanb, et al. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol : in vitro and in vivo evaluation [J]. Eur J Pharm Biopharm, 2003, 56 : 453-459.
[20] Bok Ki Kang, Jin Soo Lee, Se Kang Chon, et al. Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs [J]. Int J Pharm, 2004, 274 : 65-73.